President John Saharek on the ImprimisRx pipeline, details 3 products

John Saharek, president of ImprimisRX, speaks with Ophthalmology Times Europe's David Hutton on three new products the company will be featuring during the American Academy of Ophthalmology's 2021 annual meeting, including:

• Moxi-Brom (moxifloxacin hydrochloride 0.5% and bromfenac sodium sesquihydrate 0.075%)
• Klarity-CL drops (cyclosporine 0.1% / loteprednol etabonate 0.2% ophthalmic suspension)
• Tim-Brim-Dor-Bim (prednisolone acetate 1%, gatifloxacin 0.5%, bromfenac 0.075%).

The American Academy of Ophthalmology (AAO) annual meeting was held November 12 to 15 at the Ernest N. Morial Convention Centre in New Orleans, Louisiana, United States. The event included Subspecialty Days and a virtual component for remote participation.

Related Content: Additional AAO content | Retina | Inflammation & Infection